» Articles » PMID: 12928492

Intense Myocyte Formation from Cardiac Stem Cells in Human Cardiac Hypertrophy

Overview
Specialty Science
Date 2003 Aug 21
PMID 12928492
Citations 116
Authors
Affiliations
Soon will be listed here.
Abstract

It is generally believed that increase in adult contractile cardiac mass can be accomplished only by hypertrophy of existing myocytes. Documentation of myocardial regeneration in acute stress has challenged this dogma and led to the proposition that myocyte renewal is fundamental to cardiac homeostasis. Here we report that in human aortic stenosis, increased cardiac mass results from a combination of myocyte hypertrophy and hyperplasia. Intense new myocyte formation results from the differentiation of stem-like cells committed to the myocyte lineage. These cells express stem cell markers and telomerase. Their number increased >13-fold in aortic stenosis. The finding of cell clusters with stem cells making the transition to cardiogenic and myocyte precursors, as well as very primitive myocytes that turn into terminally differentiated myocytes, provides a link between cardiac stem cells and myocyte differentiation. Growth and differentiation of these primitive cells was markedly enhanced in hypertrophy, consistent with activation of a restricted number of stem cells that, through symmetrical cell division, generate asynchronously differentiating progeny. These clusters strongly support the existence of cardiac stem cells that amplify and commit to the myocyte lineage in response to increased workload. Their presence is consistent with the notion that myocyte hyperplasia significantly contributes to cardiac hypertrophy and accounts for the subpopulation of cycling myocytes.

Citing Articles

State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.

Lavin K, Coen P, Baptista L, Bell M, Drummer D, Harper S Compr Physiol. 2022; 12(2):3193-3279.

PMID: 35578962 PMC: 9186317. DOI: 10.1002/cphy.c200033.


Physical activity and fitness in childhood cancer survivors: a scoping review.

Wogksch M, Goodenough C, Finch E, Partin R, Ness K Aging Cancer. 2022; 2(4):112-128.

PMID: 35098147 PMC: 8794406. DOI: 10.1002/aac2.12042.


Accelerated Growth, Differentiation, and Ploidy with Reduced Proliferation of Right Ventricular Cardiomyocytes in Children with Congenital Heart Defect Tetralogy of Fallot.

Sukhacheva T, Serov R, Nizyaeva N, Burov A, Pavlovich S, Podurovskaya Y Cells. 2022; 11(1).

PMID: 35011735 PMC: 8750260. DOI: 10.3390/cells11010175.


The Potential Properties of Natural Compounds in Cardiac Stem Cell Activation: Their Role in Myocardial Regeneration.

Carresi C, Scicchitano M, Scarano F, Macri R, Bosco F, Nucera S Nutrients. 2021; 13(1).

PMID: 33477916 PMC: 7833367. DOI: 10.3390/nu13010275.


The Future of Direct Cardiac Reprogramming: Any Cocktail Variety?.

Lopez-Muneta L, Miranda-Arrubla J, Carvajal-Vergara X Int J Mol Sci. 2020; 21(21).

PMID: 33114756 PMC: 7663133. DOI: 10.3390/ijms21217950.


References
1.
Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami C, Anversa P . Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci U S A. 1998; 95(15):8801-5. PMC: 21157. DOI: 10.1073/pnas.95.15.8801. View

2.
Anversa P, Kajstura J . Ventricular myocytes are not terminally differentiated in the adult mammalian heart. Circ Res. 1998; 83(1):1-14. DOI: 10.1161/01.res.83.1.1. View

3.
Guerra S, Leri A, Wang X, Finato N, Di Loreto C, Beltrami C . Myocyte death in the failing human heart is gender dependent. Circ Res. 1999; 85(9):856-66. DOI: 10.1161/01.res.85.9.856. View

4.
Scholzen T, Gerdes J . The Ki-67 protein: from the known and the unknown. J Cell Physiol. 2000; 182(3):311-22. DOI: 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9. View

5.
Morin S, Charron F, Robitaille L, Nemer M . GATA-dependent recruitment of MEF2 proteins to target promoters. EMBO J. 2000; 19(9):2046-55. PMC: 305697. DOI: 10.1093/emboj/19.9.2046. View